The Effect of Long-Acting Beta-2 Agonist Monotherapy and Long-Acting Anticholinergic Monotherapy to Quality-of-Life in Group B Stable COPD Patients. Jurnal Respirologi Indonesia, [S. l.], v. 42, n. 4, p. 277–281, 2022. DOI: 10.36497/jri.v42i4.370. Disponível em: http://www.jurnalrespirologi.org/index.php/jri/article/view/370. Acesso em: 4 jul. 2025.